Detalhe da pesquisa
1.
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Cell Rep;
43(4): 113063, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38578829
2.
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes.
Cancer Cell;
42(5): 732-735, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38579722
3.
Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects.
Mol Cancer;
23(1): 56, 2024 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38491381
4.
Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model.
iScience;
27(2): 108879, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38327771
5.
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients.
Clin Cancer Res;
30(4): 803-813, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060202
6.
Regulation of HHLA2 expression in kidney cancer and myeloid cells.
BMC Cancer;
23(1): 1039, 2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37891555
7.
Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states.
Cell Rep Med;
4(9): 101189, 2023 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37729872
8.
Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.
J Immunother Cancer;
11(8)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586773
9.
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer.
Nat Cell Biol;
25(9): 1346-1358, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591951
10.
Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma.
Cancer Immunol Res;
11(8): 1114-1124, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279009
11.
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy.
Oncologist;
2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37368355
12.
Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer.
Nat Cancer;
4(7): 984-1000, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365326
13.
The Role of the Pathologist in Renal Cell Carcinoma Management.
Hematol Oncol Clin North Am;
37(5): 849-862, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37258353
14.
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B).
J Immunother Cancer;
11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36948504
15.
Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma.
Cell Rep Med;
4(2): 100947, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36812889
16.
Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states.
bioRxiv;
2023 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36712053
17.
Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.
Nat Commun;
14(1): 346, 2023 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681680
18.
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma.
J Immunother Cancer;
10(12)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36549781
19.
Mitochondrial transporter expression patterns distinguish tumor from normal tissue and identify cancer subtypes with different survival and metabolism.
Sci Rep;
12(1): 17035, 2022 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36220979
20.
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma.
Cancer Cell;
40(9): 939-956.e16, 2022 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35985343